Cardiology

The Chan Zuckerberg Initiative has awarded $1.49 million to research projects involving Stanford Medicine scientists who will investigate emerging ideas about the role of inflammation in disease.

The award will fund a research program for heart-health technology and a clinical trial for treating hypertension in black and Hispanic participants and in drivers for ride-hailing companies.

From migraines to strokes to brain bleeds, the symptoms of HHT are varied. Diagnosis is often delayed, yet early care can prevent both bothersome and deadly side effects.

Robert Harrington, the new president of the American Heart Association, recently discussed his views on technology and diversity in medicine.

A new study asserts that disease-management clinics, home visits by nurses and nurse case management should become the standard of care for elderly patients with heart failure after they are discharged from the hospital.

Stanford researchers have found that drug-coated nanoparticles limit the development of atherosclerosis in mice, without side effects.

A recent decision by the Food and Drug Administration opened the door for Sharon Kramer of Atherton, California, to undergo a less-invasive heart valve replacement.

Hongjie Dai, Julie Parsonnet and Joseph Wu are among the 90 regular members and 10 international members elected this year to the academy, which aims to provide independent, scientifically informed analysis and recommendations on health issues.

A large, international study led by Stanford and New York University found that invasive procedures are no better than medications and lifestyle advice at treating heart disease that's severe but stable.

Study shows that Apple Watch app can identify heart rhythm irregularities, which can help catch atrial fibrillation.

Stanford scientists and their collaborators have discovered the protective role played by identity-morphing cells — and the gene behind them — in atherosclerosis, according to a new study.